# The Efficacy and Safety of Puerarin in Obesity Treatment

> **NCT06968208** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Metabolic Diseases
- Obesity/Therapy

## Interventions

- **DRUG:** Puerarin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06968208
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2029-01-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06968208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06968208, "The Efficacy and Safety of Puerarin in Obesity Treatment". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06968208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*